Pacira BioSciences Inc (PCRX)
17.70
+0.03
(+0.17%)
USD |
NASDAQ |
Nov 07, 16:00
17.71
+0.01
(+0.06%)
Pre-Market: 20:00
Pacira BioSciences Revenue (Annual): 674.98M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 674.98M |
| December 31, 2022 | 666.82M |
| December 31, 2021 | 541.53M |
| December 31, 2020 | 429.65M |
| December 31, 2019 | 421.03M |
| December 31, 2018 | 337.28M |
| December 31, 2017 | 286.63M |
| December 31, 2016 | 276.37M |
| Date | Value |
|---|---|
| December 31, 2015 | 249.00M |
| December 31, 2014 | 197.67M |
| December 31, 2013 | 85.55M |
| December 31, 2012 | 39.08M |
| December 31, 2011 | 15.69M |
| December 31, 2010 | 14.56M |
| December 31, 2009 | 15.01M |
| December 31, 2008 | 13.92M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
421.03M
Minimum
2019
674.98M
Maximum
2023
546.80M
Average
541.53M
Median
2021
Revenue (Annual) Benchmarks
| Cyclo Therapeutics Inc | 1.076M |
| Revance Therapeutics Inc | 234.04M |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.490M |
| iBio Inc | 0.225M |